Guotai Junan Securities Co.Ltd(601211)
About Guangdong taienkang Pharmaceutical Co., Ltd
Special verification report of strategic investors for initial public offering and listing on GEM
Guangdong taienkang Pharmaceutical Co., Ltd. (hereinafter referred to as “taienkang” or “issuer”) plans to make an initial public offering of shares in China and be listed on the gem (hereinafter referred to as “this offering”).
Guotai Junan Securities Co.Ltd(601211) (hereinafter referred to as “sponsor (lead underwriter)”, “lead underwriter” or ” Guotai Junan Securities Co.Ltd(601211) “) serves as the sponsor (lead underwriter) of this offering.
In accordance with the relevant provisions of the detailed rules for the implementation of the issuance and underwriting business of initial public offering of securities on the gem of Shenzhen Stock Exchange (revised in 2021) (SZS [2021] No. 919) (hereinafter referred to as the “detailed rules”), some senior managers of the issuer Core employees have established Guotai Junan Securities Co.Ltd(601211) Junxiang gem tynkang No. 1 strategic placement collective asset management plan (hereinafter referred to as “tynkang No. 1 asset management plan”) to participate in the strategic placement of this offering.
Guotai Junan Securities Co.Ltd(601211) Zhengyu Investment Co., Ltd. (hereinafter referred to as “Zhengyu investment”) is an alternative investment subsidiary established by Guotai Junan Securities Co.Ltd(601211) according to law. The recommendation institution (lead underwriter) Guotai Junan Securities Co.Ltd(601211) participates in the strategic placement of tynkon this offering through securities margin investment. 1、 Verification of basic information of strategic investors in this offering
1. Guotai Junan Securities Co.Ltd(601211) Junxiang gem tyenkang No. 1 strategic placement collective asset management plan
(1) Basic information
1) Name: Guotai Junan Securities Co.Ltd(601211) Junxiang gem tyenkang No. 1 strategic placement collective asset management plan
2) Date of establishment: January 26, 2022
3) Filing time: January 28, 2022
4) Product Code: stw031
5) Scale of raised funds: 108.32 million yuan
6) Manager: Shanghai Guotai Junan Securities Co.Ltd(601211) Securities Asset Management Co., Ltd
7) Custodian: Industrial Bank Co.Ltd(601166)
8) Actual controlling entity: Shanghai Guotai Junan Securities Co.Ltd(601211) Securities Asset Management Co., Ltd
(2) Resolution of the board of directors
The ninth meeting of the Fourth Board of directors of the issuer deliberated and approved the proposal on the participation of some senior managers and core employees of the company in the strategic placement of the company’s initial public offering and listing on the gem, and agreed that some senior managers and core employees should subscribe for and establish a special asset management plan, and participate in the strategic placement of this offering with a special asset management plan.
(3) Executives and employees involved in this offering and strategic placement
The fund raised by taienkang No. 1 asset management plan is no more than 108.32 million yuan. The names, positions and proportions of participants are as follows:
Whether it is the share of special plans of listed companies, serial number of special plans, name, position, senior management of the company, core (10000 yuan) proportion (%) employees
1 the chairman and general manager of Zheng Hanjie is 389835.99
2 the director and deputy general manager of Chen Chun is 458 4.23
Li Ting, director, deputy general manager, yes
Board Secretary 453.4
4 Lin Sanhua’s chief financial officer is 458 4.23
5 Lin Zili supervisor and general manager assistant is 458 4.23
Xu Lihong, chairman of the board of supervisors and Auditor
6 director 275 2.54
The manager of Zheng hanqiang’s administrative department is 238 2.20
8. The director of Sun Tao’s marketing center is 183 1.69
Xing Peiping, general manager of taienkang pharmaceutical factory
9.183 1.69
Luo Yihua, general manager of Anhui taienkang, is 183.1.69
The general manager of Zheng Ruihan technology industry is 183 1.69
Xu Zhiyi, general manager of taienkang equipment factory
12.183 1.69
Zhong Qiang Shandong Huabo Kaisheng Chemical Co., Ltd
13 R & D center project leader 183 1.69
14 Chen Shaojun, deputy director of OTC promotion department, 147 1.36
15 Hu hanzhao, the manager of infrastructure department, is 147 1.36
16 Liang Ying’s manager of audit department is 147 1.36
17 Zhou Guixi the manager of finance department is 147 1.36
18. The cashier of Xu Xiaoyan’s finance department is 147.1.36
19 Cai Xiaoqiang, director of human resources department, 147 1.36
20 Zhang Songhui human resources manager is 147 1.36
21 He Zhenliang, director of sales control department, 147 1.36
22 Li Mingming, director of OTC promotion department, 147 1.36
23 Li Yongfeng, the director of sales department is 110 1.02
Wang Jianxin, supervisor and deputy general manager of Sales Department
24.147 1.36
25 the director of Yirui medical department is 147 1.36
Yang Mingxia ophthalmology Division Sales Manager
26.147 1.36
Zhao Xiaoliang ophthalmology department sales manager
27.147 1.36
Xiao Lingyun, administrative manager of Ophthalmology Division
28.147 1.36
Li Damei taienkang equipment factory produces
29 Department Manager 147 1.36
Yang Ping, vice president of taienkang pharmaceutical factory
30 manager 147 1.36
Liu Xianyang taienkang pharmaceutical factory produces
31 director 147 1.36
Ke Jiangying, executive vice president of Anhui taienkang
32 general manager 147 1.36
Li Xin Anhui taienkang Quality Certification Co., Ltd
33 obligee 147 1.36
Li Yong Anhui taienkang Production Co., Ltd
34.147 1.36
Li Hai Anhui taienkang Bozhou factory is
35 principal 147 1.36
36 Wei Shengjun, deputy director of sales department, 147 1.36
37 he Chenggang, director of investment promotion department, 147 1.36
Total 10832100.00
Note 1: the raised capital of tynkang No. 1 asset management plan is 108.32 million yuan, and 100% of the raised capital can be used to participate in the subscription, that is, to pay the price of this strategic placement.
Note 2: the difference in the mantissa between the sum of the total number and the number of each part is caused by rounding. Note 3: the final number of subscribed shares will be confirmed after the issue price is determined.
(4) Identification of actual dominant subject
Shanghai Guotai Junan Securities Co.Ltd(601211) Securities Asset Management Co., Ltd. (hereinafter referred to as ” Guotai Junan Securities Co.Ltd(601211) asset management”) is the actual controlling subject of tyenkang No. 1 asset management plan. Shanghai Guotai Junan Securities Co.Ltd(601211) Securities Asset Management Co., Ltd. has actual control over the investment decision-making and independent operation arrangement of taienkang No. 1 asset management plan, the rights exercise arrangement of relevant shareholders of the issuer and the implementation arrangement of voting at the general meeting of shareholders of the issuer.
(5) Strategic placement qualification
According to the resolution of the 9th meeting of the 4th board of directors of the issuer and the management contract of Guotai Junan Securities Co.Ltd(601211) Junxiang gem taienkang No. 1 strategic placement collective asset management plan and other documents, some senior managers and core employees of the issuer participated in the strategic placement of this offering through the establishment of taienkang No. 1 asset management plan.
Taienkang No. 1 asset management plan has been filed with the securities investment fund industry association on January 28, 2022. It is verified that the personnel participating in the strategic placement of this issuance are the senior management and core employees of the issuer, which have an important impact on the production and operation of the issuer. They have signed labor contracts or labor contracts with the issuer or its wholly-owned subsidiaries and branches. Among them, He Zhenliang and Li Hai are retirees and have established labor relations with the issuer, Other personnel have established labor relations with the issuer; Relevant senior managers and key employees set up taienkang No. 1 asset management plan to participate in the strategic placement of this issuance, which has been deliberated and approved by the board of directors of the issuer; The issuer’s qualification to participate in the strategic placement (item 1 of Article 32 of the detailed rules for the implementation of taienkang’s strategic placement plan) complies with the provisions of Article 32 of the detailed rules for the implementation of the strategic placement plan.
(6) Sources of subscription funds participating in strategic placement
The funds used by the participants of taienkang No. 1 asset management plan to participate in this strategic placement are their own funds. (7) Commitment letter related to this offering
In accordance with relevant laws and regulations and the strategy on participating in the initial public offering and listing on the gem of Guangdong taienkang Pharmaceutical Co., Ltd. signed by Guotai Junan Securities Co.Ltd(601211) asset management
